Åvall-Lundqvist E - Search Results

1

Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic lymphadenectomy in women with high-risk endometrial cancer: A randomised controlled trial.

Salehi S, Åvall-Lundqvist E, Legerstam B, Carlson JW, Falconer H. Salehi S, et al. Eur J Cancer. 2017 Jul;79:81-89. doi: 10.1016/j.ejca.2017.03.038. Epub 2017 Apr 29. Eur J Cancer. 2017. PMID: 28463759 Clinical Trial.

2

Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma.

Avall-Lundqvist EH, Sjövall K, Nilsson BR, Eneroth PH. Avall-Lundqvist EH, et al. Eur J Cancer. 1992;28A(10):1695-702. doi: 10.1016/0959-8049(92)90071-9. Eur J Cancer. 1992. PMID: 1389488

3

Initial experiences with serum alkaline DNase activity in monitoring the effects of therapy for carcinoma of the uterine cervix.

Avall Lundqvist EH, Sjövall K, Eneroth PH. Avall Lundqvist EH, et al. Eur J Cancer. 1991;27(10):1313-5. doi: 10.1016/0277-5379(91)90103-k. Eur J Cancer. 1991. PMID: 1835604

4

The impact of tumour angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma.

Avall-Lundqvist EH, Silfverswärd C, Aspenblad U, Nilsson BR, Auer GU. Avall-Lundqvist EH, et al. Eur J Cancer. 1997 Oct;33(11):1799-804. doi: 10.1016/s0959-8049(97)00161-5. Eur J Cancer. 1997. PMID: 9470836

5

HSP60 predicts survival in advanced serous ovarian cancer.

Hjerpe E, Egyhazi S, Carlson J, Stolt MF, Schedvins K, Johansson H, Shoshan M, Avall-Lundqvist E. Hjerpe E, et al. Int J Gynecol Cancer. 2013 Mar;23(3):448-55. doi: 10.1097/IGC.0b013e318284308b. Int J Gynecol Cancer. 2013. PMID: 23429486

6

Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer.

Hjerpe E, Egyhazi Brage S, Carlson J, Frostvik Stolt M, Schedvins K, Johansson H, Shoshan M, Avall-Lundqvist E. Hjerpe E, et al. BMC Clin Pathol. 2013 Nov 19;13(1):30. doi: 10.1186/1472-6890-13-30. BMC Clin Pathol. 2013. PMID: 24252137 Free PMC article.

7

Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).

Dahm-Kähler P, Borgfeldt C, Holmberg E, Staf C, Falconer H, Bjurberg M, Kjölhede P, Rosenberg P, Stålberg K, Högberg T, Åvall-Lundqvist E. Dahm-Kähler P, et al. Gynecol Oncol. 2017 Jan;144(1):167-173. doi: 10.1016/j.ygyno.2016.10.039. Epub 2016 Nov 3. Gynecol Oncol. 2017. PMID: 27817932

8

Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register study-On behalf of the Swedish Gynecological Cancer Group.

Stålberg K, Kjølhede P, Bjurberg M, Borgfeldt C, Dahm-Kähler P, Falconer H, Holmberg E, Staf C, Tholander B, Åvall-Lundqvist E, Rosenberg P, Högberg T. Stålberg K, et al. Int J Cancer. 2017 Jun 15;140(12):2693-2700. doi: 10.1002/ijc.30707. Epub 2017 Apr 12. Int J Cancer. 2017. PMID: 28340503 Free article.

9

Long-term quality of life after comprehensive surgical staging of high-risk endometrial cancer - results from the RASHEC trial.

Salehi S, Brandberg Y, Åvall-Lundqvist E, Suzuki C, Johansson H, Legerstam B, Falconer H. Salehi S, et al. Acta Oncol. 2018 Dec;57(12):1671-1676. doi: 10.1080/0284186X.2018.1521987. Epub 2018 Oct 5. Acta Oncol. 2018. PMID: 30289327 Clinical Trial.

10

Lymphedema, serious adverse events, and imaging 1 year after comprehensive staging for endometrial cancer: results from the RASHEC trial.

Salehi S, Åvall-Lundqvist E, Brandberg Y, Johansson H, Suzuki C, Falconer H. Salehi S, et al. Int J Gynecol Cancer. 2019 Jan;29(1):86-93. doi: 10.1136/ijgc-2018-000019. Int J Gynecol Cancer. 2019. PMID: 30640688 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page